Clinical Trials Logo

Clinical Trial Summary

From May 2016 till May 2018 all breast cancer patients with operable disease submitted to surgery after neoadjuvant treatment would be divided in four groups considering initially clinical axillary stage, axillary procedure that was done, axillary response to preoperative systemic treatment and pathological axillary stage. In first postoperative year all patients will be monitored for appearance of locoregional and distant recurrence.


Clinical Trial Description

From May 2017 SLNB after neoadjuvant treatment was introduced in clinical practice for breast cancer patients presenting initially with involved axilla but shifted to clinically negative followed neoadjuvant treatment. This retrospective analysis is designed for period of one year before and one year later to compare the clinical outcomes for this patients in the setting where ALND was performed to the setting where SLNB was performed. The main hypothesis was to establish that SLNB after neoadjuvant treatment, in initially node positive breast cancer patients that achieve complete clinical remission following neoadjuvant treatment, is reliable alternative to ALND in maintenance of locoregional control of disease. For the purpose of this trial four groups were created and the results would be compared among them. In first postoperative year patients were monitored for the appearance of locoregional and distant recurrence. Data were collected individually for each patient and recorded in register. All data are available to all members of investigation team, members of Ethic Committee and statistician. Data collected in this trial would be used for publication. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03833960
Study type Observational
Source Clinical Hospital Center Rijeka
Contact
Status Completed
Phase
Start date May 2016
Completion date June 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03719833 - Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents
Recruiting NCT00654342 - Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer N/A
Not yet recruiting NCT04140188 - SLNB After Nipple Sparing Mastectomy N/A
Recruiting NCT01564264 - Sentinel Node Biopsy in Endometrial Cancer N/A
Recruiting NCT06212440 - Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy N/A
Terminated NCT03630653 - Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse N/A
Active, not recruiting NCT04986306 - The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients
Recruiting NCT05512468 - Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy N/A
Recruiting NCT03199560 - Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy Phase 4
Not yet recruiting NCT04932460 - Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy N/A
Recruiting NCT03680833 - Sentinel Node Detection in Cervical Cancer N/A
Completed NCT03200704 - A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer Phase 3
Recruiting NCT04403867 - The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
Not yet recruiting NCT05703295 - Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
Enrolling by invitation NCT05942170 - The Combination of Preoperative MRI and SLN in the Surgical Management of CC and EC N/A
Recruiting NCT03937414 - Intraoperative Molecular Diagnosis of Sentinel Lymph Node In Breast Cancer Patients N/A
Recruiting NCT06120439 - Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy N/A
Terminated NCT05457842 - A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery Phase 2